What is CBD
Cannabidiol is one of the active ingredients in cannabis.
Cannabidiol, or CBD, is one of the active cannabinoids (ingredients) in cannabis. CBD is considered to have many medical applications, and works in concert with THC to obtain what is known as the entourage effect. CBD is often extracted from the marijuana plant in the form of liquid oil and has slowly begun use as a treatment for Dravet syndrome in some US states.
Dravet syndrome is a form of epilepsy that begins during the infancy of a child’s life. This disease creates lethal seizures often with several instances per day. While there are reports that CBD is effective in the treatment of those who suffer epileptic events there is a lack of sufficient medical evidence to understand its effectiveness and safety.
Raphael Mechoulam is a cannabinoid researcher in Israel who believes Avidekel to be the first CBD enriched cannabis plant with almost no THC. Some researchers currently believe that CBD may also serve as a way to open receptors CB1 and CB2, allowing them to take in more of the available THC in the plant. A Canadian company has recently developed an aerosol drug for oral administration containing a nearly even mixture of THC and CBD. It was approved in 2005 under the name Sativex and is currently being used to alleviate pain associated with multiple sclerosis.
CBD is a Schedule two drug in Canada allowing for some medical uses, in the United States however it is not so clear cut. While marijuana itself it a Schedule I substance in the United States the Controlled Substances Act does not list CBD under any Schedule of the act. This has not stopped the Drug Enforcement Administration from treating CBD as a Schedule I substance. So while it may appear the drug is not currently regulated it is being treated as such by authority officials.
It is believed that due to CBD not being listed on the controlled substances act that CBD may be legal under federal law assuming it meets specific requirements. There is an exemption that allows products to be manufactured and sold in the United States if they produced from mature stalks and the fibers produced by them. This includes hemp oil and extracts of hemp products which may have high CBD content.
There is a US patent on file #6,630,507 titled “Cannabinoids as antioxidants and neuroprotectants” which is assigned to “The United States of America as Represented by The Department of Health and Human Services.” This patent mentions the use of CBD as a use as an anti-epileptic as well as a potential treatment for glaucoma. There is also a claim that using CBD may prevent neurotoxicity in the human brain as well as lower intraocular pressure in acute doses. The drug is also listed to have high antioxidant activity which can be used in oxidation associated diseases.